About
Lynx Biosciences develops immuno-oncology and immunology therapies using a proprietary patient-based ex vivo disease biology platform combined with multi-omic data analysis to identify druggable targets and accelerate drug discovery.
Explore Lynx Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.